Saturday, April 28 (29)

 

7:30 am - 5 pm Registration Open

10 - 11:30 am Resource Center Open

6:30 am-6:45 am

Commercially Supported Breakfast Symposium

Current Understanding of the Peripheral and Central Components Involved in the Pain Pathway and Their Roles in Chronic Pain and Future Therapeutics

Chronic pain is an under-recognized and under-resourced public health problem with devastating impact. The World Health Organization’s ranking of 310 ailments places low back and neck pain as the leading “global burden of disease” worldwide, with painful musculoskeletal conditions (e.g., arthritis) a major threat to mobility that compromises the health of individuals and societies around the world.

The overall prevalence of common, predominantly musculoskeletal pain conditions (e.g., arthritis, rheumatism, chronic back or neck problems, and frequent severe headaches) was estimated at 43 percent among adults in the United States.

As the population ages and the prevalence of chronic musculoskeletal conditions continues to rise and clinicians find themselves struggling to manage pain and restore function associated with these conditions.

Peripheral and central sensitization of nociceptive pathways appear to ultimately drive the perpetuation of pain and play a role in the chronic aspects of the disease. Conventional pain management pharmacotherapy targets systemic inflammation and pain; increasing awareness on future pharmacological targets is warranted in the context of the underlying pathophysiological mechanisms of chronic pain.

Educational Objectives:

  • Discuss disease burden of chronic pain, with a focus on musculoskeletal pain.
  • Discuss and contrast the most widely used guidelines for the management of chronic pain.
  • Increase awareness of the high unmet medical need in this disease area.
  • Review the pathophysiology of chronic pain and the role of various mediators including NGF in chronic pain pathophysiology and their role in central and peripheral sensitization.
  • Review the rationale behind various treatments for chronic pain that are currently under investigation.

AAPM provided breakfast.

Activity funded by: Pfizer, Inc & Eli Lilly and Company

Speakers:

Patrick W. Mantyh, PhD
Charles E. Argoff, MD

8–9 am

General Session III and Award Presentations (104) Featured

View a recording of this live session when you purchase 2018 Annual Meeting On Demand.

The AAPM 34th Annual Meeting Saturday program will kick off with a truly must-attend plenary program featuring guest speaker Vanila Singh, MD, Chief Medical Officer for HHS. Dr. Singh practices at Stanford University where she is Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine. AAPM Past President and Stanford University Redlich Professor of Anesthesiology, Perioperative and Pain Medicine, Sean Mackey, MD PhD, will also present during this session.

The Patient Advocacy Award and Presidential Excellence Award for Education will be presented.

The National Strategy and U.S. Task Force on Pain and Opioids

The U.S. Department of Health and Human Services Chief Medical Officer, Dr. Vanila M. Singh, will discuss the National Pain Strategy; her leadership in developing the U.S. Task Force on Pain and Opioids; and the ongoing mission, challenges, and opportunities to address the dual crises facing the country.

Moderator: Sean Mackey, MD PhD

Shared Solutions for Our Pain and Opioid Crises

Sean Mackey, MD PhD

The National Strategy and U.S. Task Force on Pain and Opioids

Vanila M. Singh, MD

Subscribe to this RSS feed